Skip to main content

Table 1 Baseline characteristics of patients with ASD with and without GERD

From: Prevalence and key radiographic spinal malalignment parameters that influence the risk for gastroesophageal reflux disease in patients treated surgically for adult spinal deformity

Variable

Overall (n = 71)

GERD+ (n = 37)

GERD− (n = 34)

P value

Age (y)

70.4 ± 7.4

70.8 ± 6.54

70.0 ± 8.23

0.6663

Female/male gender (n)

62/9

32/5

30/4

0.7297

TK, standing (°)

24.9 ± 19.0

29.3 ± 19.8

20.7 ± 17.3

0.0620

TLK, standing (°)

19.34 ± 18.4

23.7 ± 19.7

15.2 ± 16.1

0.0561

LL, standing (°)

13.2 ± 19.6

14.4 ± 18.2

12.2 ± 21.7

0.6571

PI (°)

53.1 ± 9.6

54.4 ± 11.2

51.9 ± 8.1

0.2963

PT (°)

37.5 ± 10.6

38.4 ± 10.0

36.5 ± 11.2

0.4759

SS (°)

17.0 ± 11.9

16.9 ± 10.1

17.2 ± 13.4

0.8947

SVA (mm)

104.8 ± 64.6

116.9 ± 56.8

93.1 ± 71.0

0.1354

PI-LL(°)

29.3 ± 16.5

27.52 ± 17.3

31.0 ± 15.4

0.3864

Cobb angle (°)

23.6 ± 16.9

26.9 ± 17.9

20.1 ± 15.1

0.0918

TK, FBB (°)

19.9 ± 15.8

24.2 ± 16.4

14.8 ± 13.6

<0.05

TLK, FBB (°)

7.2 ± 14.4

13.6 ± 15.2

−0.42 ± 8.8

<0.0001

LL, FBB (°)

31.9 ± 16.3

29.9 ± 15.8

34.3 ± 17.0

0.0918

Cobb angle ~30°/30°~ (n)

 

22/15

29/5

<0.05

Number of thoracolumbar vertebral fractures (n)

0.55 ± 1.1

0.78 ± 1.3

0.32 ± 0.84

0.0876

Intake of NSAIDs

15 (21.1%)

10 (27.02%)

5 (14.7%)

0.252

Intake of bisphosphonates

8 (11.3%)

6 (16.2%)

2 (5.88%)

0.264

Intake of PPI

34 (47.9%)

34 (91.9%)

0

 
  1. Data are mean ± standard deviation unless otherwise shown
  2. Bolded values with P < 0.05
  3. ASD adult spinal deformity, FBB fulcrum backward-bending, GERD gastroesophageal reflux disease, LL lumbar lordosis, TK thoracic kyphosis, TLK thoracolumbar kyphosis, PI pelvic incidence; PT pelvic tilt, SS sacral slope, SVA sagittal vertical axis, NSAIDs non-steroidal anti-inflammatory drugs, PPI Proton pump inhibitor